Skip to main content
Log in

Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases

  • Letter to the editor
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Jäger U (2003) Innovative strategies in lymphoma therapy. Wien Klin Wochenschr 115 (13–14): 462–470

    Article  PubMed  Google Scholar 

  • Gisslinger H, Kees M (2003) Therapy strategies for multiple myeloma: current status. Wien Klin Wochenschr 115 (13–14): 451–461

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Politta S, Favet L, Kerl K, et al (2008) Bortezomib-induced skin eruption. Dermatology 216: 156–158

    Article  CAS  PubMed  Google Scholar 

  • Gerecitano J, Goy A, Wright J, et al (2006) Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response? Br J Haematol 134 (4): 391–398

    Article  CAS  PubMed  Google Scholar 

  • Hideshima T, Mitsiades C, Akiyama M, et al (2003) Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. Blood 101: 1530–1534

    Article  CAS  PubMed  Google Scholar 

  • Richardson PG, Sonneveld P, Schuster M, et al (2007) Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial. Blood 110: 3557–3560

    Article  CAS  PubMed  Google Scholar 

  • Garcia-Navarro X, Puig L, Fernandez-Figueras MT, et al (2007) Bortezomib-associated cutaneous vasculitis. Br J Dermatol 157: 799–801

    Article  CAS  PubMed  Google Scholar 

  • Min CK, Lee S, Kim YJ, et al (2006) Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro-inflammatory cytokines. Eur J Haematol 76 (3): 265–268

    Article  CAS  PubMed  Google Scholar 

  • Kokuba H, Aurelian L, Burnett J (1999) Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions. J Invest Dermatol 113: 808–815

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edwin Bölke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerber, P., Bölke, E., Buhren, B. et al. Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases. Wien Klin Wochenschr 121, 723–724 (2009). https://doi.org/10.1007/s00508-009-1267-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-009-1267-7

Keywords

Navigation